Behavioral Health Epidemiology
Our mission is to conduct high-impact epidemiological research that identifies the distribution and determinants of, and evaluates interventions and services for, substance abuse, psychiatric disorders, and related infectious diseases such as tuberculosis (TB), human immunodeficiency virus (HIV), and sexually transmitted diseases (STDs).
Focus Areas
- Risk factor epidemiology of mental and substance use disorders
- Identification and characterization of the genetic determinants of complex diseases and their interaction with environmental factors
- Epidemiology of TB and HIV in specific populations, disparities in treatment and interventions to overcome barriers to early treatment
- Treatment, services, and comparative effectiveness research for mental and substance use disorders
Capabilities
- Epidemiological methods
- Statistic methodology including variable, multilevel, and survival analysis
- Genome-wide association and candidate gene studies
- Infectious disease prevalence studies
- Evaluations of diagnostic tests for TB
- Psychiatric instrumentation
Projects
- Center for Substance Abuse Treatment's (CSAT's) Services Accountability Improvement System (SAIS)
- Examining Pathways Among Co-occurring Mental and Substance Use Disorders
- Prevalence and Correlates of Psychiatric and Substance Use Disorders Among Older Adults
- Non-Medical Use and Diversion of Prescription Psychostimulants
- Collaborative Study on the Genetics of Nicotine Dependence
- Genome-wide Association Study of HIV-1 Host Genetics Among Injection Drug Users
- Genetics of Nicotine Dependence Among African Americans
- TB Epidemiologic Studies Consortium
Clients
- Substance Abuse and Mental Health Services Administration
- National Institute on Drug Abuse
- National Institute of Mental Health
- National Cancer Institute
- Centers for Disease Control and Prevention
- Eli Lilly and Company
rti.org